MRI screening and targeted biopsies could reduce overdiagnoses of prostate cancer

vendredi 9 juillet 2021

Most countries have not introduced nationwide prostate-cancer screening, as current methods result in overdiagnoses and excessive and unnecessary biopsies. A new study by researchers at Karolinska Institutet in Sweden, which is published in The New England Journal of Medicine, indicates that screening by magnetic resonance imaging (MRI) and targeted biopsies could potentially cut overdiagnoses by half. MRI screening and targeted biopsies could reduce overdiagnoses of prostate cancer

0 commentaires:

Enregistrer un commentaire